Search Results - "Pagnucco, Layla"

Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients by Maggiolo, Franco, Gulminetti, Roberto, Pagnucco, Layla, Digaetano, Margherita, Cervo, Adriana, Valenti, Daniela, Callegaro, Annapaola, Mussini, Cristina

“…The use of DTG-containing two-drug regimens is one of the most promising solutions to the need to ease the management of HIV treatment without harming its…”
Get full text

Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients by Maggiolo, Franco, Gulminetti, Roberto, Pagnucco, Layla, Digaetano, Margherita, Benatti, Simone, Valenti, Daniela, Callegaro, Annapaola, Ripamonti, Diego, Mussini, Cristina

“…Little is known about the applicability of dual treatments based on integrase inhibitors. We explored the combination of lamivudine + dolutegravir as an option…”
Get full text

Factors Associated With Weight Gain in People Treated With Dolutegravir by Taramasso, Lucia, Bonfanti, Paolo, Ricci, Elena, Orofino, Giancarlo, Squillace, Nicola, Menzaghi, Barbara, De Socio, Giuseppe Vittorio, Madeddu, Giordano, Pellicanò, Giovanni Francesco, Pagnucco, Layla, Celesia, Benedetto Maurizio, Calza, Leonardo, Conti, Federico, Martinelli, Canio Vito, Valsecchi, Laura, Cascio, Antonio, Bolla, Cesare, Maggi, Paolo, Vichi, Francesca, Dentone, Chiara, Angioni, Goffredo, Mastroianni, Antonio, Falasca, Katia, Cenderello, Giovanni, Di Biagio, Antonio

“…Abstract Background An unexpected excess in weight gain has recently been reported in the course of dolutegravir (DTG) treatment. The aim of the present study…”
Get full text

Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre by Perlini, Stefano, Canevari, Fabrizio, Cortesi, Sergio, Sgromo, Vito, Brancaglione, Antonella, Contri, Enrico, Pettenazza, Pietro, Salinaro, Francesco, Speciale, Francesco, Sechi, Giuseppe, Mare, Claudio, Cutti, Sara, Novelli, Viola, Marena, Carlo, Muzzi, Alba, Bruno, Raffaele, Palo, Alessandra

“…Since December 2019, the world has been facing the life-threatening disease, named Coronavirus disease-19 (COVID-19), recognized as a pandemic by the World…”
Get full text

Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? by Lombardi, Andrea, Colaneri, Marta, Vijayagopal, Kesav Aditya, Sambo, Margherita, Legnazzi, Patrizia, Sacchi, Paolo, Zuccaro, Valentina, Maiocchi, Laura, Maserati, Renato, Gulminetti, Roberto, Pagnucco, Layla, Novati, Stefano, Zanaboni, Domenico, Michelone, Giuseppe, Ludovisi, Serena, Mondelli, Mario U., Bruno, Raffaele

“…Direct acting antiviral agents (DAAs) have revolutionized the landscape of chronic hepatitis C (CHC) enabling treatment of all those infected. It remains to be…”
Get full text

A challenging case of SARS-CoV-2- AIDS and Nocardiosis coinfection from the SMatteo COVID-19 Registry (SMACORE) by Colaneri, Marta, Lupi, Matteo, Sachs, Michele, Ludovisi, Serena, Di Matteo, Angela, Pagnucco, Layla, Gulminetti, Roberto, Mariani, Bianca, Fabbiani, Massimiliano, Bruno, Raffaele

“…The COVID-19 pandemic is posing an unprecedented threat worldwide. One issue that has faltered, though, concerns the underestimated risk to trade all for…”
Get full text

Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy by Castagna, Antonella, Rusconi, Stefano, Gulminetti, Roberto, Bonora, Stefano, Mazzola, Giovanni, Quiros-Roldan, Maria E, De Socio, Giuseppe V, Ladisa, Nicoletta, Carosella, Sinibaldo, Cattelan, Annamaria, Di Giambenedetto, Simona, Mena, Maurizio, Poli, Andrea, Galli, Laura, Riva, Agostino

“…We evaluated the efficacy and safety of a two-drug regimen including dolutegravir (DTG) and unboosted atazanavir (uATV) in 151 HIV-1 infected patients with…”
Get full text

Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohort by Soria, Alessandro, Fava, Marco, Bernasconi, Davide P., Lapadula, Giuseppe, Colella, Elisa, Valsecchi, Maria G., Migliorino, Guglielmo M., D'Ambrosio, Roberta, Landonio, Simona, Schiavini, Monica, Spinetti, Angiola, Carriero, Canio, Degasperi, Elisabetta, Cologni, Giuliana, Gatti, Federico, Viganò, Paolo, Hasson, Hamid, Uberti‐Foppa, Caterina, Pasulo, Luisa, Baiguera, Chiara, Rossotti, Roberto, Vinci, Maria, Puoti, Massimo, Giorgini, Alessia, Menzaghi, Barbara, Lombardi, Andrea, Pan, Angelo, Aghemo, Alessio, Grossi, Paolo A., Boldizzoni, Roberto, Colombo, Silvia, Viganò, Mauro, Rumi, Maria G., Del Poggio, Paolo, Valenti, Luca, Giglio, Omar, De Bona, Anna, d'Arminio Monforte, Antonella, Colombo, Alberto, Spinelli, Ombretta, Pigozzi, Marie G., Molteni, Chiara, Bonfanti, Paolo, Terreni, Natalia, Perini, Paolo, Capretti, Andrea, Bella, Daniele, Liani, Cecilia, Polo, Silvia, Aimo, Gianpiero, Pagnucco, Layla, Bhoori, Sherrie, Centenaro, Riccardo, Graffeo, Massimo, Ciaccio, Antonio, Dionigi, Elena, Lazzaroni, Sergio, Carderi, Isabella, Di Marco, Mariella, Rizzardini, Giuliano, Noventa, Franco, Lampertico, Pietro, Fagiuoli, Stefano

“…Background & Aims In the direct‐acting antiviral era, treatment of genotype‐3 HCV (HCV‐GT3) is still challenging. Real‐life comparisons between recommended…”
Get full text

Two-drug regimens with dolutegravir for maintaining viral suppression: looking at the right companion by Castagna, Antonella

Get full text

A challenging case of SARS-CoV-2- AIDS and Nocardiosis coinfection from the SMatteo COvid19 REgistry (SMACORE) by Colaneri, Marta, Lupi, Matteo, Sachs, Michele, Ludovisi, Serena, Di Matteo, Angela, Pagnucco, Layla, Gulminetti, Roberto, Mariani, Bianca, Fabbiani, Massimiliano, Bruno, Raffaele

Get full text

Breast Cancer and HIV: State of the Art and Practical Implications by Lasagna, Angioletta, Zuccaro, Valentina, Sacchi, Paolo, Pagnucco, Layla, Ferraris, Elisa, Armani, Giovanna, Rizzo, Gianpiero, Tancredi, Richard J., Pedrazzoli, Paolo

“…Breast cancer is most common in women, and its incidence in HIV population, after the introduction of antiretroviral therapy, has increased to a level…”
Get full text

Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy by Melazzini, Federica, Colaneri, Marta, Fumoso, Federica, Freddi, Giulia, Lenti, Marco Vincenzo, Pieri, Teresa Chiara, Piloni, Davide, Noris, Patrizia, Pieresca, Carla, Preti, Paola Stefania, Russo, Mariaconcetta, Corsico, Angelo, Tavazzi, Guido, Baldanti, Fausto, Triarico, Antonio, Mojoli, Francesco, Bruno, Raffaele, Di Sabatino, Antonio

“…Preliminary evidence supports the notion that COVID-19 patients may have an increased susceptibility to develop venous thromboembolism (VTE). However, the…”
Get full text

Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy by Melazzini, Federica, Colaneri, Marta, Fumoso, Federica, Freddi, Giulia, Lenti, Marco Vincenzo, Pieri, Teresa Chiara, Piloni, Davide, Noris, Patrizia, Pieresca, Carla, Preti, Paola Stefania, Russo, Mariaconcetta, Corsico, Angelo, Tavazzi, Guido, Baldanti, Fausto, Triarico, Antonio, Mojoli, Francesco, Bruno, Raffaele, Di Sabatino, Antonio

“…In the original publication of the article, the names of the COVID-19 Task Force were not listed as contributors…”
Get full text